Results 241 to 250 of about 101,164 (260)

Triple-negative breast tumors with a twist: a radiological and histological approach to salivary gland-type neoplasms

Learning objectives Background Findings and procedure details Conclusion Personal information and conflict of interest ...
openaire   +1 more source

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Laura A Huppert, Özge Gümüsay, Damé Idossa   +2 more
exaly  

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets

Cell Metabolism, 2021
Yue Gong, Yun-Song Yang, Tian-Jian Yu
exaly  

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021

Cancers, 2022
Maroun Bou Zerdan, Tala Ghorayeb, Sabine Allam   +2 more
exaly  

Pathogenesis of Triple-Negative Breast Cancer

Annual Review of Pathology: Mechanisms of Disease, 2022
Fatemeh Derakhshan, Jorge S Reis-Filho
exaly  

Survival Study of Triple-Negative and Non–Triple-Negative Breast Cancer in a Brazilian Cohort

Clinical Medicine Insights: Oncology, 2018
Homero Gonçalves Junior, Maximiliano Ribeiro Guerra, Jane Rocha Duarte Cintra   +2 more
exaly  

Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study

Annals of Oncology, 2019
E P Winer, D Loirat, David W Cescon
exaly  

Identification of Metastasis-Associated Genes in Triple-Negative Breast Cancer Using Weighted Gene Co-expression Network Analysis

Evolutionary Bioinformatics, 2020
Yijie Chen, Zhaoming Zhong, Lina Tang
exaly  

Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study

Annals of Oncology, 2019
Sherene Loi, D Toppmeyer, David W Cescon   +2 more
exaly  

Metabolic Reprogramming in Triple-Negative Breast Cancer

Frontiers in Oncology, 2020
Xiangyu Sun, Mozhi Wang, Xueting Yu
exaly